Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Openenheimer Industry Update -

Perhaps this could also be the reason that so few MMP Portfolio license have been sold, "problems" with the BoD?

Just like the earlier "credibility problems" at EMC, Lexmark, and Sun, for example, with shareholder dissent?

Crossflo has a product which is not only "up-and-running" but also has government-supplier endorsement.

Sure seems like there are credibility issues with the product because of the current BoD. NOT.

Imagine the scenario:

The evaluation shows that Crossflo meets 100% of the requirements but there are credibility issues with the BoD. The next best solution will cover 80% of the requirements and will quite probably end up costing twice as much but the BoD is delightful.

Product or people?

Decisions, decisions, decisions... LOL





Be well

Share
New Message
Please login to post a reply